SLSBio(Specialty Lab Solution Bio)에스엘에스바이오
246250 · KOSDAQ · ₩246250 · 에스엘에스바이오
₩1,969 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Other Market Notice (Regarding Postponement of Clearance Sale)기타시장안내 (정리매매 보류 관련)Oct 26, 2026Open on DART
Predicted impact: Medium
Notice on delisting liquidation trading being held; delisting already reported, so lowered one level.
- Trading halt주권매매거래정지 (투자자 보호)Oct 26, 2026Open on DART
Predicted impact: Medium
Trading halt for investor protection amid delisting process; delisting already reported, lowered one level.
- Other management matters기타경영사항(자율공시) (상장폐지결정 등 효력정지 가처분 신청)Oct 26, 2026Open on DART
Predicted impact: Medium
Injunction filed to suspend delisting decision; a legal outcome could decide whether shares keep trading.
- Delisting주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)Oct 23, 2026Open on DART
High impactPredicted impact: High
KOSDAQ committee decided to delist the company, a major trading-ending regulatory ruling.
- Delisting기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내)Oct 23, 2026Open on DART
High impactPredicted impact: High
KOSDAQ committee decided to delist the company, a major trading-ending regulatory ruling.
- Other Market Notice (Submission of Details of Implementation of Improvement Plan)기타시장안내 (개선계획 이행내역서 제출)Sep 21, 2026Open on DART
- Delisting기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)Aug 31, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 29, 2026Open on DART
- Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)Jun 2, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 19, 2026Open on DART
- Other Market Notice (Added Reason: Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유추가)Mar 12, 2026Open on DART
- Audit report submitted감사보고서제출Mar 12, 2026Open on DART
- Occurrence of Semi-Annual or Quarterly Revenue Shortfall반기또는분기매출액미달사실발생Mar 12, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 10, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 10, 2026Open on DART
- Other Market Notice (Notice on Concern of Additional Reason for Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유추가 우려 안내)Feb 25, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Feb 25, 2026Open on DART
- Delisting내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생Feb 25, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 25, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Designation as Unfaithful Disclosure Company (Reversal of Disclosure)불성실공시법인지정 (공시번복)Dec 5, 2025Open on DART
- Notice of Designation as Unfaithful Disclosure Company (Reversal of Disclosure)불성실공시법인지정예고 (공시번복)Nov 21, 2025Open on DART
- Other Market Notice (Addition of Grounds for Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 추가)Nov 14, 2025Open on DART
- Occurrence of Semi-Annual or Quarterly Revenue Shortfall반기또는분기매출액미달사실발생Nov 14, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Other Material Management Matters (Decision on Acquisition of Tangible Assets Withdrawn)기타주요경영사항 (유형자산 양수결정 철회)Nov 3, 2025Open on DART
- Material Improvement Plan Regarding Substantive Review for Listing Eligibility (Voluntary Disclosure)상장적격성실질심사관련주요개선계획(자율공시)Nov 3, 2025Open on DART
- [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)[기재정정]주요사항보고서(유형자산양수결정)Nov 3, 2025Open on DART
- Trading halt주권매매거래정지기간변경 (개선기간 부여)Oct 31, 2025Open on DART
- Other Market Notice (Result of KOSDAQ Committee Deliberation and Resolution, and Grant of Improvement Period)기타시장안내 (코스닥시장위원회 심의·의결 결과 및 개선기간 부여 안내)Oct 31, 2025Open on DART
- Other Material Management Matters (Resolution of Business Suspension Grounds Due to Acquisition of Drug Product Approval)기타주요경영사항 (의약품 품목허가 취득에 따른 영업정지 사유 해소)Oct 27, 2025Open on DART
- Delisting기타시장안내 (상장폐지 관련 이의신청서 접수)Sep 29, 2025Open on DART
- Delisting주권매매거래정지기간변경 (상장폐지 사유 발생)Sep 8, 2025Open on DART
- Other Market Notice (Announcement of Results of Corporate Review Committee Meeting)기타시장안내 (기업심사위원회 개최 결과 안내)Sep 8, 2025Open on DART
- [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Sep 4, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Other Market Notice (Submission of Improvement Plan)기타시장안내 (개선계획서 제출)Aug 11, 2025Open on DART
- [Amended Filing] Major Matters Report (Decision on Acquisition of Tangible Assets)[기재정정]주요사항보고서(유형자산양수결정)Aug 4, 2025Open on DART
- Trading halt주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)Jul 21, 2025Open on DART
- Other Market Notice (Decision to Subject to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상 결정)Jul 21, 2025Open on DART
- Other Market Notice (Extension of Investigation Period to Determine Whether Substantive Review Applies)기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)Jun 30, 2025Open on DART
- [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Jun 30, 2025Open on DART
- [Amended Filing] Major Matters Report (Business Suspension)[기재정정]주요사항보고서(영업정지)Jun 11, 2025Open on DART
- Other Market Notice (Notice on Deadline for Decision on Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)Jun 10, 2025Open on DART
- Major Matters Report (Business Suspension)주요사항보고서(영업정지)Jun 10, 2025Open on DART
- Other Market Notice (Notice on Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 관련 안내)Jun 9, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: SLSBio(Specialty Lab Solution Bio) / 에스엘에스바이오 / 246250 / KRX:246250
Source: KRX statistical information